Micro Forceps Comprehensive Study by Type (Straight, Curved, Alligator/crocodile, Cupped, Bipolar, Other), Application (Ophthalmology, Cardiovascular, Neurovascular, Gastrointestinal, Obstetrics and gynecology, Urology, Oncology, ENT, Reconstructive surgery, Other), End-use (Hospitals, Ambulatory surgical centres, Research institutes) Players and Region - Global Market Outlook to 2026

Micro Forceps Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Micro Forceps is a device used to hold delicate tissues or vasculature. The device has a small tip of 0.25 mm thick and is designed in such a way that maximum grip is controlled in confined spaces and delicate surgeries. The micro forceps may rise in the forecasted period owing to the rise in incidence of chronic diseases and rise in health care expenditure.This growth is primarily driven by Rise in Number of Surgeries Among the Ageing Population and Increasing Prevalence of Lifestyle Disorder, Growing Demand For Minimal Invasive Surgical Procedure and Increasing Incidence of Chronic Disease.

Globally, a noticeable market trend is evident Technology Advancement in Micro Instrument. Major Players, such as B Braun (Germany), BD (United States), MicroSurgical Technology (United States), Antibe Therapeutics (Canada), Strong Vision Technology (United States), Action Medical (United Kingdom), Medicon (Japan), KLS Martin Group (Germany), US Endoscopy (United States), Geuder Group (Germany), Symmetry Surgical (United States), Antibe Therapeutics Inc. (Canada), TAKAYAMA Instrument (Japan), Synovis Micro Companies (United States), Mercian Surgical Supply Co Ltd. (United Kingdom), Wexler Surgical (United States) and Labtician Ophthalmics (Canada) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In 19th February 2019, Intutive Surgical, Inc. a global technology leader that develops, manufactures and market robotic products designed to improve clinical outcomes. The U.S. Food and Drug Administration (FDA) announced the Ion endoluminal system to enable minimally invasive biopsy in the peripheral lung. The Ion system's flexible biopsy needle (called the Flexision Biopsy Needle) can also pass through very tight bends via Ion's catheter to collect tissue in the peripheral lung. The catheter 2mm working channel accommodate other biopsy tools, such as biopsy forceps or cytology brushes, if necessary.

Regulatory Insights:
According to the U.S. Food and Drug Administration (FDA) - The surgical instrument for general use is a nonpowered, hand-held, or hand-manipulated device, either reusable or disposable, intended to be used in various general surgical procedures. The device includes the applicator, clip applier, biopsy brush, manual dermabrasion brush, scrub brush, cannula, ligature carrier, chisel, clamp, contractor, curette, cutter, dissector, elevator, skin graft expander, file, forceps, gouge, instrument guide, needle guide and others.

Market Drivers
  • Rise in Number of Surgeries Among the Ageing Population and Increasing Prevalence of Lifestyle Disorder
  • Growing Demand For Minimal Invasive Surgical Procedure
  • Increasing Incidence of Chronic Disease

Market Trend
  • Technology Advancement in Micro Instrument

Restraints
  • Stringent Safety Regulation Related to Micro Forceps
  • Growing Adoption of Surgical Procedure

Opportunities
Emerging Markets Offer Lucrative Growth Opportunities
Challenges
Dearth of Skilled Surgeons and Intraoperative Issues By Surgeons and Changing Decision Making Power and Cost-Benefit Analysis

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Micro Forceps Study Sheds Light on
The Micro Forceps Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Micro Forceps industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Micro Forceps industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Straight
  • Curved
  • Alligator/crocodile
  • Cupped
  • Bipolar
  • Other
By Application
  • Ophthalmology
  • Cardiovascular
  • Neurovascular
  • Gastrointestinal
  • Obstetrics and gynecology
  • Urology
  • Oncology
  • ENT
  • Reconstructive surgery
  • Other
By End-use
  • Hospitals
  • Ambulatory surgical centres
  • Research institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Number of Surgeries Among the Ageing Population and Increasing Prevalence of Lifestyle Disorder
      • 3.2.2. Growing Demand For Minimal Invasive Surgical Procedure
      • 3.2.3. Increasing Incidence of Chronic Disease
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Surgeons and Intraoperative Issues By Surgeons
      • 3.3.2. Changing Decision Making Power and Cost-Benefit Analysis
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Micro Instrument
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Micro Forceps, by Type, Application, End-use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Micro Forceps (Value)
      • 5.2.1. Global Micro Forceps by: Type (Value)
        • 5.2.1.1. Straight
        • 5.2.1.2. Curved
        • 5.2.1.3. Alligator/crocodile
        • 5.2.1.4. Cupped
        • 5.2.1.5. Bipolar
        • 5.2.1.6. Other
      • 5.2.2. Global Micro Forceps by: Application (Value)
        • 5.2.2.1. Ophthalmology
        • 5.2.2.2. Cardiovascular
        • 5.2.2.3. Neurovascular
        • 5.2.2.4. Gastrointestinal
        • 5.2.2.5. Obstetrics and gynecology
        • 5.2.2.6. Urology
        • 5.2.2.7. Oncology
        • 5.2.2.8. ENT
        • 5.2.2.9. Reconstructive surgery
        • 5.2.2.10. Other
      • 5.2.3. Global Micro Forceps by: End-use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory surgical centres
        • 5.2.3.3. Research institutes
      • 5.2.4. Global Micro Forceps Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Micro Forceps: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. B Braun (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BD (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. MicroSurgical Technology (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Antibe Therapeutics (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Strong Vision Technology (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Action Medical (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medicon (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. KLS Martin Group (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. US Endoscopy (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Geuder Group (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Symmetry Surgical (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Antibe Therapeutics Inc. (Canada)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. TAKAYAMA Instrument (Japan)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Synovis Micro Companies (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Mercian Surgical Supply Co Ltd. (United Kingdom)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Wexler Surgical (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Labtician Ophthalmics (Canada)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
  • 7. Global Micro Forceps Sale, by Type, Application, End-use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Micro Forceps (Value)
      • 7.2.1. Global Micro Forceps by: Type (Value)
        • 7.2.1.1. Straight
        • 7.2.1.2. Curved
        • 7.2.1.3. Alligator/crocodile
        • 7.2.1.4. Cupped
        • 7.2.1.5. Bipolar
        • 7.2.1.6. Other
      • 7.2.2. Global Micro Forceps by: Application (Value)
        • 7.2.2.1. Ophthalmology
        • 7.2.2.2. Cardiovascular
        • 7.2.2.3. Neurovascular
        • 7.2.2.4. Gastrointestinal
        • 7.2.2.5. Obstetrics and gynecology
        • 7.2.2.6. Urology
        • 7.2.2.7. Oncology
        • 7.2.2.8. ENT
        • 7.2.2.9. Reconstructive surgery
        • 7.2.2.10. Other
      • 7.2.3. Global Micro Forceps by: End-use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory surgical centres
        • 7.2.3.3. Research institutes
      • 7.2.4. Global Micro Forceps Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Micro Forceps: by Type(USD Million)
  • Table 2. Micro Forceps Straight , by Region USD Million (2015-2020)
  • Table 3. Micro Forceps Curved , by Region USD Million (2015-2020)
  • Table 4. Micro Forceps Alligator/crocodile , by Region USD Million (2015-2020)
  • Table 5. Micro Forceps Cupped , by Region USD Million (2015-2020)
  • Table 6. Micro Forceps Bipolar , by Region USD Million (2015-2020)
  • Table 7. Micro Forceps Other , by Region USD Million (2015-2020)
  • Table 8. Micro Forceps: by Application(USD Million)
  • Table 9. Micro Forceps Ophthalmology , by Region USD Million (2015-2020)
  • Table 10. Micro Forceps Cardiovascular , by Region USD Million (2015-2020)
  • Table 11. Micro Forceps Neurovascular , by Region USD Million (2015-2020)
  • Table 12. Micro Forceps Gastrointestinal , by Region USD Million (2015-2020)
  • Table 13. Micro Forceps Obstetrics and gynecology , by Region USD Million (2015-2020)
  • Table 14. Micro Forceps Urology , by Region USD Million (2015-2020)
  • Table 15. Micro Forceps Oncology , by Region USD Million (2015-2020)
  • Table 16. Micro Forceps ENT , by Region USD Million (2015-2020)
  • Table 17. Micro Forceps Reconstructive surgery , by Region USD Million (2015-2020)
  • Table 18. Micro Forceps Other , by Region USD Million (2015-2020)
  • Table 19. Micro Forceps: by End-use(USD Million)
  • Table 20. Micro Forceps Hospitals , by Region USD Million (2015-2020)
  • Table 21. Micro Forceps Ambulatory surgical centres , by Region USD Million (2015-2020)
  • Table 22. Micro Forceps Research institutes , by Region USD Million (2015-2020)
  • Table 23. South America Micro Forceps, by Country USD Million (2015-2020)
  • Table 24. South America Micro Forceps, by Type USD Million (2015-2020)
  • Table 25. South America Micro Forceps, by Application USD Million (2015-2020)
  • Table 26. South America Micro Forceps, by End-use USD Million (2015-2020)
  • Table 27. Brazil Micro Forceps, by Type USD Million (2015-2020)
  • Table 28. Brazil Micro Forceps, by Application USD Million (2015-2020)
  • Table 29. Brazil Micro Forceps, by End-use USD Million (2015-2020)
  • Table 30. Argentina Micro Forceps, by Type USD Million (2015-2020)
  • Table 31. Argentina Micro Forceps, by Application USD Million (2015-2020)
  • Table 32. Argentina Micro Forceps, by End-use USD Million (2015-2020)
  • Table 33. Rest of South America Micro Forceps, by Type USD Million (2015-2020)
  • Table 34. Rest of South America Micro Forceps, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Micro Forceps, by End-use USD Million (2015-2020)
  • Table 36. Asia Pacific Micro Forceps, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Micro Forceps, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Micro Forceps, by Application USD Million (2015-2020)
  • Table 39. Asia Pacific Micro Forceps, by End-use USD Million (2015-2020)
  • Table 40. China Micro Forceps, by Type USD Million (2015-2020)
  • Table 41. China Micro Forceps, by Application USD Million (2015-2020)
  • Table 42. China Micro Forceps, by End-use USD Million (2015-2020)
  • Table 43. Japan Micro Forceps, by Type USD Million (2015-2020)
  • Table 44. Japan Micro Forceps, by Application USD Million (2015-2020)
  • Table 45. Japan Micro Forceps, by End-use USD Million (2015-2020)
  • Table 46. India Micro Forceps, by Type USD Million (2015-2020)
  • Table 47. India Micro Forceps, by Application USD Million (2015-2020)
  • Table 48. India Micro Forceps, by End-use USD Million (2015-2020)
  • Table 49. South Korea Micro Forceps, by Type USD Million (2015-2020)
  • Table 50. South Korea Micro Forceps, by Application USD Million (2015-2020)
  • Table 51. South Korea Micro Forceps, by End-use USD Million (2015-2020)
  • Table 52. Taiwan Micro Forceps, by Type USD Million (2015-2020)
  • Table 53. Taiwan Micro Forceps, by Application USD Million (2015-2020)
  • Table 54. Taiwan Micro Forceps, by End-use USD Million (2015-2020)
  • Table 55. Australia Micro Forceps, by Type USD Million (2015-2020)
  • Table 56. Australia Micro Forceps, by Application USD Million (2015-2020)
  • Table 57. Australia Micro Forceps, by End-use USD Million (2015-2020)
  • Table 58. Rest of Asia-Pacific Micro Forceps, by Type USD Million (2015-2020)
  • Table 59. Rest of Asia-Pacific Micro Forceps, by Application USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Micro Forceps, by End-use USD Million (2015-2020)
  • Table 61. Europe Micro Forceps, by Country USD Million (2015-2020)
  • Table 62. Europe Micro Forceps, by Type USD Million (2015-2020)
  • Table 63. Europe Micro Forceps, by Application USD Million (2015-2020)
  • Table 64. Europe Micro Forceps, by End-use USD Million (2015-2020)
  • Table 65. Germany Micro Forceps, by Type USD Million (2015-2020)
  • Table 66. Germany Micro Forceps, by Application USD Million (2015-2020)
  • Table 67. Germany Micro Forceps, by End-use USD Million (2015-2020)
  • Table 68. France Micro Forceps, by Type USD Million (2015-2020)
  • Table 69. France Micro Forceps, by Application USD Million (2015-2020)
  • Table 70. France Micro Forceps, by End-use USD Million (2015-2020)
  • Table 71. Italy Micro Forceps, by Type USD Million (2015-2020)
  • Table 72. Italy Micro Forceps, by Application USD Million (2015-2020)
  • Table 73. Italy Micro Forceps, by End-use USD Million (2015-2020)
  • Table 74. United Kingdom Micro Forceps, by Type USD Million (2015-2020)
  • Table 75. United Kingdom Micro Forceps, by Application USD Million (2015-2020)
  • Table 76. United Kingdom Micro Forceps, by End-use USD Million (2015-2020)
  • Table 77. Netherlands Micro Forceps, by Type USD Million (2015-2020)
  • Table 78. Netherlands Micro Forceps, by Application USD Million (2015-2020)
  • Table 79. Netherlands Micro Forceps, by End-use USD Million (2015-2020)
  • Table 80. Rest of Europe Micro Forceps, by Type USD Million (2015-2020)
  • Table 81. Rest of Europe Micro Forceps, by Application USD Million (2015-2020)
  • Table 82. Rest of Europe Micro Forceps, by End-use USD Million (2015-2020)
  • Table 83. MEA Micro Forceps, by Country USD Million (2015-2020)
  • Table 84. MEA Micro Forceps, by Type USD Million (2015-2020)
  • Table 85. MEA Micro Forceps, by Application USD Million (2015-2020)
  • Table 86. MEA Micro Forceps, by End-use USD Million (2015-2020)
  • Table 87. Middle East Micro Forceps, by Type USD Million (2015-2020)
  • Table 88. Middle East Micro Forceps, by Application USD Million (2015-2020)
  • Table 89. Middle East Micro Forceps, by End-use USD Million (2015-2020)
  • Table 90. Africa Micro Forceps, by Type USD Million (2015-2020)
  • Table 91. Africa Micro Forceps, by Application USD Million (2015-2020)
  • Table 92. Africa Micro Forceps, by End-use USD Million (2015-2020)
  • Table 93. North America Micro Forceps, by Country USD Million (2015-2020)
  • Table 94. North America Micro Forceps, by Type USD Million (2015-2020)
  • Table 95. North America Micro Forceps, by Application USD Million (2015-2020)
  • Table 96. North America Micro Forceps, by End-use USD Million (2015-2020)
  • Table 97. United States Micro Forceps, by Type USD Million (2015-2020)
  • Table 98. United States Micro Forceps, by Application USD Million (2015-2020)
  • Table 99. United States Micro Forceps, by End-use USD Million (2015-2020)
  • Table 100. Canada Micro Forceps, by Type USD Million (2015-2020)
  • Table 101. Canada Micro Forceps, by Application USD Million (2015-2020)
  • Table 102. Canada Micro Forceps, by End-use USD Million (2015-2020)
  • Table 103. Mexico Micro Forceps, by Type USD Million (2015-2020)
  • Table 104. Mexico Micro Forceps, by Application USD Million (2015-2020)
  • Table 105. Mexico Micro Forceps, by End-use USD Million (2015-2020)
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Company Basic Information, Sales Area and Its Competitors
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Micro Forceps: by Type(USD Million)
  • Table 124. Micro Forceps Straight , by Region USD Million (2021-2026)
  • Table 125. Micro Forceps Curved , by Region USD Million (2021-2026)
  • Table 126. Micro Forceps Alligator/crocodile , by Region USD Million (2021-2026)
  • Table 127. Micro Forceps Cupped , by Region USD Million (2021-2026)
  • Table 128. Micro Forceps Bipolar , by Region USD Million (2021-2026)
  • Table 129. Micro Forceps Other , by Region USD Million (2021-2026)
  • Table 130. Micro Forceps: by Application(USD Million)
  • Table 131. Micro Forceps Ophthalmology , by Region USD Million (2021-2026)
  • Table 132. Micro Forceps Cardiovascular , by Region USD Million (2021-2026)
  • Table 133. Micro Forceps Neurovascular , by Region USD Million (2021-2026)
  • Table 134. Micro Forceps Gastrointestinal , by Region USD Million (2021-2026)
  • Table 135. Micro Forceps Obstetrics and gynecology , by Region USD Million (2021-2026)
  • Table 136. Micro Forceps Urology , by Region USD Million (2021-2026)
  • Table 137. Micro Forceps Oncology , by Region USD Million (2021-2026)
  • Table 138. Micro Forceps ENT , by Region USD Million (2021-2026)
  • Table 139. Micro Forceps Reconstructive surgery , by Region USD Million (2021-2026)
  • Table 140. Micro Forceps Other , by Region USD Million (2021-2026)
  • Table 141. Micro Forceps: by End-use(USD Million)
  • Table 142. Micro Forceps Hospitals , by Region USD Million (2021-2026)
  • Table 143. Micro Forceps Ambulatory surgical centres , by Region USD Million (2021-2026)
  • Table 144. Micro Forceps Research institutes , by Region USD Million (2021-2026)
  • Table 145. South America Micro Forceps, by Country USD Million (2021-2026)
  • Table 146. South America Micro Forceps, by Type USD Million (2021-2026)
  • Table 147. South America Micro Forceps, by Application USD Million (2021-2026)
  • Table 148. South America Micro Forceps, by End-use USD Million (2021-2026)
  • Table 149. Brazil Micro Forceps, by Type USD Million (2021-2026)
  • Table 150. Brazil Micro Forceps, by Application USD Million (2021-2026)
  • Table 151. Brazil Micro Forceps, by End-use USD Million (2021-2026)
  • Table 152. Argentina Micro Forceps, by Type USD Million (2021-2026)
  • Table 153. Argentina Micro Forceps, by Application USD Million (2021-2026)
  • Table 154. Argentina Micro Forceps, by End-use USD Million (2021-2026)
  • Table 155. Rest of South America Micro Forceps, by Type USD Million (2021-2026)
  • Table 156. Rest of South America Micro Forceps, by Application USD Million (2021-2026)
  • Table 157. Rest of South America Micro Forceps, by End-use USD Million (2021-2026)
  • Table 158. Asia Pacific Micro Forceps, by Country USD Million (2021-2026)
  • Table 159. Asia Pacific Micro Forceps, by Type USD Million (2021-2026)
  • Table 160. Asia Pacific Micro Forceps, by Application USD Million (2021-2026)
  • Table 161. Asia Pacific Micro Forceps, by End-use USD Million (2021-2026)
  • Table 162. China Micro Forceps, by Type USD Million (2021-2026)
  • Table 163. China Micro Forceps, by Application USD Million (2021-2026)
  • Table 164. China Micro Forceps, by End-use USD Million (2021-2026)
  • Table 165. Japan Micro Forceps, by Type USD Million (2021-2026)
  • Table 166. Japan Micro Forceps, by Application USD Million (2021-2026)
  • Table 167. Japan Micro Forceps, by End-use USD Million (2021-2026)
  • Table 168. India Micro Forceps, by Type USD Million (2021-2026)
  • Table 169. India Micro Forceps, by Application USD Million (2021-2026)
  • Table 170. India Micro Forceps, by End-use USD Million (2021-2026)
  • Table 171. South Korea Micro Forceps, by Type USD Million (2021-2026)
  • Table 172. South Korea Micro Forceps, by Application USD Million (2021-2026)
  • Table 173. South Korea Micro Forceps, by End-use USD Million (2021-2026)
  • Table 174. Taiwan Micro Forceps, by Type USD Million (2021-2026)
  • Table 175. Taiwan Micro Forceps, by Application USD Million (2021-2026)
  • Table 176. Taiwan Micro Forceps, by End-use USD Million (2021-2026)
  • Table 177. Australia Micro Forceps, by Type USD Million (2021-2026)
  • Table 178. Australia Micro Forceps, by Application USD Million (2021-2026)
  • Table 179. Australia Micro Forceps, by End-use USD Million (2021-2026)
  • Table 180. Rest of Asia-Pacific Micro Forceps, by Type USD Million (2021-2026)
  • Table 181. Rest of Asia-Pacific Micro Forceps, by Application USD Million (2021-2026)
  • Table 182. Rest of Asia-Pacific Micro Forceps, by End-use USD Million (2021-2026)
  • Table 183. Europe Micro Forceps, by Country USD Million (2021-2026)
  • Table 184. Europe Micro Forceps, by Type USD Million (2021-2026)
  • Table 185. Europe Micro Forceps, by Application USD Million (2021-2026)
  • Table 186. Europe Micro Forceps, by End-use USD Million (2021-2026)
  • Table 187. Germany Micro Forceps, by Type USD Million (2021-2026)
  • Table 188. Germany Micro Forceps, by Application USD Million (2021-2026)
  • Table 189. Germany Micro Forceps, by End-use USD Million (2021-2026)
  • Table 190. France Micro Forceps, by Type USD Million (2021-2026)
  • Table 191. France Micro Forceps, by Application USD Million (2021-2026)
  • Table 192. France Micro Forceps, by End-use USD Million (2021-2026)
  • Table 193. Italy Micro Forceps, by Type USD Million (2021-2026)
  • Table 194. Italy Micro Forceps, by Application USD Million (2021-2026)
  • Table 195. Italy Micro Forceps, by End-use USD Million (2021-2026)
  • Table 196. United Kingdom Micro Forceps, by Type USD Million (2021-2026)
  • Table 197. United Kingdom Micro Forceps, by Application USD Million (2021-2026)
  • Table 198. United Kingdom Micro Forceps, by End-use USD Million (2021-2026)
  • Table 199. Netherlands Micro Forceps, by Type USD Million (2021-2026)
  • Table 200. Netherlands Micro Forceps, by Application USD Million (2021-2026)
  • Table 201. Netherlands Micro Forceps, by End-use USD Million (2021-2026)
  • Table 202. Rest of Europe Micro Forceps, by Type USD Million (2021-2026)
  • Table 203. Rest of Europe Micro Forceps, by Application USD Million (2021-2026)
  • Table 204. Rest of Europe Micro Forceps, by End-use USD Million (2021-2026)
  • Table 205. MEA Micro Forceps, by Country USD Million (2021-2026)
  • Table 206. MEA Micro Forceps, by Type USD Million (2021-2026)
  • Table 207. MEA Micro Forceps, by Application USD Million (2021-2026)
  • Table 208. MEA Micro Forceps, by End-use USD Million (2021-2026)
  • Table 209. Middle East Micro Forceps, by Type USD Million (2021-2026)
  • Table 210. Middle East Micro Forceps, by Application USD Million (2021-2026)
  • Table 211. Middle East Micro Forceps, by End-use USD Million (2021-2026)
  • Table 212. Africa Micro Forceps, by Type USD Million (2021-2026)
  • Table 213. Africa Micro Forceps, by Application USD Million (2021-2026)
  • Table 214. Africa Micro Forceps, by End-use USD Million (2021-2026)
  • Table 215. North America Micro Forceps, by Country USD Million (2021-2026)
  • Table 216. North America Micro Forceps, by Type USD Million (2021-2026)
  • Table 217. North America Micro Forceps, by Application USD Million (2021-2026)
  • Table 218. North America Micro Forceps, by End-use USD Million (2021-2026)
  • Table 219. United States Micro Forceps, by Type USD Million (2021-2026)
  • Table 220. United States Micro Forceps, by Application USD Million (2021-2026)
  • Table 221. United States Micro Forceps, by End-use USD Million (2021-2026)
  • Table 222. Canada Micro Forceps, by Type USD Million (2021-2026)
  • Table 223. Canada Micro Forceps, by Application USD Million (2021-2026)
  • Table 224. Canada Micro Forceps, by End-use USD Million (2021-2026)
  • Table 225. Mexico Micro Forceps, by Type USD Million (2021-2026)
  • Table 226. Mexico Micro Forceps, by Application USD Million (2021-2026)
  • Table 227. Mexico Micro Forceps, by End-use USD Million (2021-2026)
  • Table 228. Research Programs/Design for This Report
  • Table 229. Key Data Information from Secondary Sources
  • Table 230. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Micro Forceps: by Type USD Million (2015-2020)
  • Figure 5. Global Micro Forceps: by Application USD Million (2015-2020)
  • Figure 6. Global Micro Forceps: by End-use USD Million (2015-2020)
  • Figure 7. South America Micro Forceps Share (%), by Country
  • Figure 8. Asia Pacific Micro Forceps Share (%), by Country
  • Figure 9. Europe Micro Forceps Share (%), by Country
  • Figure 10. MEA Micro Forceps Share (%), by Country
  • Figure 11. North America Micro Forceps Share (%), by Country
  • Figure 12. Global Micro Forceps share by Players 2020 (%)
  • Figure 13. Global Micro Forceps share by Players (Top 3) 2020(%)
  • Figure 14. Global Micro Forceps share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. B Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 17. B Braun (Germany) Revenue: by Geography 2020
  • Figure 18. BD (United States) Revenue, Net Income and Gross profit
  • Figure 19. BD (United States) Revenue: by Geography 2020
  • Figure 20. MicroSurgical Technology (United States) Revenue, Net Income and Gross profit
  • Figure 21. MicroSurgical Technology (United States) Revenue: by Geography 2020
  • Figure 22. Antibe Therapeutics (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Antibe Therapeutics (Canada) Revenue: by Geography 2020
  • Figure 24. Strong Vision Technology (United States) Revenue, Net Income and Gross profit
  • Figure 25. Strong Vision Technology (United States) Revenue: by Geography 2020
  • Figure 26. Action Medical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Action Medical (United Kingdom) Revenue: by Geography 2020
  • Figure 28. Medicon (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Medicon (Japan) Revenue: by Geography 2020
  • Figure 30. KLS Martin Group (Germany) Revenue, Net Income and Gross profit
  • Figure 31. KLS Martin Group (Germany) Revenue: by Geography 2020
  • Figure 32. US Endoscopy (United States) Revenue, Net Income and Gross profit
  • Figure 33. US Endoscopy (United States) Revenue: by Geography 2020
  • Figure 34. Geuder Group (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Geuder Group (Germany) Revenue: by Geography 2020
  • Figure 36. Symmetry Surgical (United States) Revenue, Net Income and Gross profit
  • Figure 37. Symmetry Surgical (United States) Revenue: by Geography 2020
  • Figure 38. Antibe Therapeutics Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 39. Antibe Therapeutics Inc. (Canada) Revenue: by Geography 2020
  • Figure 40. TAKAYAMA Instrument (Japan) Revenue, Net Income and Gross profit
  • Figure 41. TAKAYAMA Instrument (Japan) Revenue: by Geography 2020
  • Figure 42. Synovis Micro Companies (United States) Revenue, Net Income and Gross profit
  • Figure 43. Synovis Micro Companies (United States) Revenue: by Geography 2020
  • Figure 44. Mercian Surgical Supply Co Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 45. Mercian Surgical Supply Co Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 46. Wexler Surgical (United States) Revenue, Net Income and Gross profit
  • Figure 47. Wexler Surgical (United States) Revenue: by Geography 2020
  • Figure 48. Labtician Ophthalmics (Canada) Revenue, Net Income and Gross profit
  • Figure 49. Labtician Ophthalmics (Canada) Revenue: by Geography 2020
  • Figure 50. Global Micro Forceps: by Type USD Million (2021-2026)
  • Figure 51. Global Micro Forceps: by Application USD Million (2021-2026)
  • Figure 52. Global Micro Forceps: by End-use USD Million (2021-2026)
  • Figure 53. South America Micro Forceps Share (%), by Country
  • Figure 54. Asia Pacific Micro Forceps Share (%), by Country
  • Figure 55. Europe Micro Forceps Share (%), by Country
  • Figure 56. MEA Micro Forceps Share (%), by Country
  • Figure 57. North America Micro Forceps Share (%), by Country
List of companies from research coverage that are profiled in the study
  • B Braun (Germany)
  • BD (United States)
  • MicroSurgical Technology (United States)
  • Antibe Therapeutics (Canada)
  • Strong Vision Technology (United States)
  • Action Medical (United Kingdom)
  • Medicon (Japan)
  • KLS Martin Group (Germany)
  • US Endoscopy (United States)
  • Geuder Group (Germany)
  • Symmetry Surgical (United States)
  • Antibe Therapeutics Inc. (Canada)
  • TAKAYAMA Instrument (Japan)
  • Synovis Micro Companies (United States)
  • Mercian Surgical Supply Co Ltd. (United Kingdom)
  • Wexler Surgical (United States)
  • Labtician Ophthalmics (Canada)
Additional players considered in the study are as follows:
Ningbo Cheng-He (China) , Cardio Care Clinic (India) , Faulhaber Pinzetten (Germany) , OPHMED (China)
Select User Access Type

Key Highlights of Report


May 2021 242 Pages 71 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Micro Forceps Market research Report?